Overview
Skellig Automation provides automation and digital transformation services for the life sciences industry, focusing on biotechnology and pharmaceutical manufacturing. It acts as a systems integrator, covering the full project lifecycle from consulting to implementation and ongoing support, including staff augmentation and project management. The company supports platforms like Emerson DeltaV, Ignition, Rockwell PharmaSuite, and Werum PAS-X, and uses Industry 4.0 methods, data strategy, and digital integration to improve compliance and performance, while remaining vendor-agnostic. Its goal is to reduce manufacturing costs and inefficiencies to make healthcare more affordable and accessible, backed by a people-first culture.
Work here?Claim your company
Simplify's take
What believers are saying
- Skellig expanded into Ireland in 2026, widening access to European biotech clients.
- The company reported 90+ engineers and 157,000+ project hours by October 2026.
- Recent hiring in DeltaV and MES roles shows active demand across current client programs.
What critics are saying
- Paul O'Sullivan shifted from CEO to President in January 2026, signaling leadership change.
- Skellig Manufacturing launched in 2026, potentially diverting attention, talent, and capital from Skellig Automation.
- Systems integration is highly replaceable; bigger firms can underbid within one procurement cycle.
What makes Skellig Automation unique
- Skellig Automation built 100+ projects and 157,000 engineering hours in 2025.
- The firm spans DeltaV, Ignition, UNICORN, Tulip, and MES across life sciences.
- Its open-architecture Industry 4.0 stack centers Unified Namespace and accessible manufacturing data.
Help us improve and share your feedback! Did you find this helpful?